Vishnuvardhan Ganesan

Vishnuvardhan Ganesan practices at Fairview Clinics Specialty in Saint Paul, Minnesota.

Vishnuvardhan Ganesan's NPI, 1952833428, was assigned on April 3, 2017. Vishnuvardhan Ganesan graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2017. Vishnuvardhan Ganesan holds Minnesota license 71363.

Vishnuvardhan Ganesan's primary practice is Fairview Clinics Specialty, at 1700 University W Ave, Saint Paul, MN 55104 in Ramsey County. The practice phone is (612) 672-6740.

Vishnuvardhan Ganesan's primary practice is Fairview Clinics Specialty in Saint Paul, Minnesota. Vishnuvardhan Ganesan is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Vishnuvardhan Ganesan to 4 more hospitals, 6 group practices and clinics and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vishnuvardhan Ganesan practices, 11 sites in all. Vendor and product names are available with a free account.

Urology is Vishnuvardhan Ganesan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Vishnuvardhan Ganesan is licensed in Minnesota.

CMS data shows 359 Medicare services from Vishnuvardhan Ganesan across 14 procedure codes in 2024, for 170 Medicare patients. Medicare paid $36,777 for them.

CMS counts 170 Medicare patients who saw Vishnuvardhan Ganesan in 2024. The largest group is 65 to 74, with 73 patients. 70% of them have high blood pressure, and 67% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vishnuvardhan Ganesan's median patient age at 70, with 38% women.

In 2024, Vishnuvardhan Ganesan wrote 688 Medicare Part D claims for 240 patients. 88% of them were for generic drugs. CMS names the drug for 577 of them, across 13 drugs with 11 or more claims each, at $29,343 in total drug cost. In 2023, CMS named 203 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Vishnuvardhan Ganesan for performance year 2024, reported as part of a group. Vishnuvardhan Ganesan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vishnuvardhan Ganesan as offering telehealth. CMS counts 14 procedures of prostate resection by Vishnuvardhan Ganesan, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Vishnuvardhan Ganesan, published from 2017 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Robotic Surgical Procedures, Equipment Design and Internship and Residency. Vishnuvardhan Ganesan has published most often in Urology. Vishnuvardhan Ganesan's most frequent co-authors are Deepak Agarwal, MD, Roger K. Khouri, MD and Gary Evan Lemack, MD.

CMS Open Payments shows 28 general payments to Vishnuvardhan Ganesan from 8 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 61% of the total. Cook Medical LLC paid the most, $1,101.

Vishnuvardhan Ganesan graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2017.